These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15557340)

  • 1. Parkin phosphorylation and modulation of its E3 ubiquitin ligase activity.
    Yamamoto A; Friedlein A; Imai Y; Takahashi R; Kahle PJ; Haass C
    J Biol Chem; 2005 Feb; 280(5):3390-9. PubMed ID: 15557340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity.
    Im E; Chung KC
    J Neurochem; 2015 Aug; 134(4):756-68. PubMed ID: 25963095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin.
    Hristova VA; Beasley SA; Rylett RJ; Shaw GS
    J Biol Chem; 2009 May; 284(22):14978-86. PubMed ID: 19339245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific Interaction Mapping of Phosphorylated Ubiquitin to Uncover Parkin Activation.
    Yamano K; Queliconi BB; Koyano F; Saeki Y; Hirokawa T; Tanaka K; Matsuda N
    J Biol Chem; 2015 Oct; 290(42):25199-211. PubMed ID: 26260794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's disease.
    Beasley SA; Hristova VA; Shaw GS
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3095-100. PubMed ID: 17360614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of altered phosphorylation on loss of function of juvenile Parkinsonism-associated genetic variants of the E3 ligase parkin.
    Aguirre JD; Dunkerley KM; Lam R; Rusal M; Shaw GS
    J Biol Chem; 2018 Apr; 293(17):6337-6348. PubMed ID: 29530980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity.
    Imai Y; Soda M; Takahashi R
    J Biol Chem; 2000 Nov; 275(46):35661-4. PubMed ID: 10973942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation.
    Avraham E; Rott R; Liani E; Szargel R; Engelender S
    J Biol Chem; 2007 Apr; 282(17):12842-50. PubMed ID: 17327227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasomal inhibition reduces parkin mRNA in PC12 and SH-SY5Y cells.
    Koch A; Lehmann-Horn K; Dächsel JC; Gasser T; Kahle PJ; Lücking CB
    Parkinsonism Relat Disord; 2009 Mar; 15(3):220-5. PubMed ID: 18586549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkin interacts with LIM Kinase 1 and reduces its cofilin-phosphorylation activity via ubiquitination.
    Lim MK; Kawamura T; Ohsawa Y; Ohtsubo M; Asakawa S; Takayanagi A; Shimizu N
    Exp Cell Res; 2007 Aug; 313(13):2858-74. PubMed ID: 17512523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UbMES and UbFluor: Novel probes for ring-between-ring (RBR) E3 ubiquitin ligase PARKIN.
    Park S; Foote PK; Krist DT; Rice SE; Statsyuk AV
    J Biol Chem; 2017 Oct; 292(40):16539-16553. PubMed ID: 28710279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational Impact on "in-Between-Ring" (IBR) Domain of PARKIN on Protein Stability and Function.
    Biswas S; Bagchi A
    Appl Biochem Biotechnol; 2021 Jun; 193(6):1603-1616. PubMed ID: 33471285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
    Hampe C; Ardila-Osorio H; Fournier M; Brice A; Corti O
    Hum Mol Genet; 2006 Jul; 15(13):2059-75. PubMed ID: 16714300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of phosphorylated UBL domain and insights into PINK1-orchestrated parkin activation.
    Aguirre JD; Dunkerley KM; Mercier P; Shaw GS
    Proc Natl Acad Sci U S A; 2017 Jan; 114(2):298-303. PubMed ID: 28007983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of parkin reveals mechanisms for ubiquitin ligase activation.
    Trempe JF; Sauvé V; Grenier K; Seirafi M; Tang MY; Ménade M; Al-Abdul-Wahid S; Krett J; Wong K; Kozlov G; Nagar B; Fon EA; Gehring K
    Science; 2013 Jun; 340(6139):1451-5. PubMed ID: 23661642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkin-phosphoubiquitin complex reveals cryptic ubiquitin-binding site required for RBR ligase activity.
    Kumar A; Chaugule VK; Condos TEC; Barber KR; Johnson C; Toth R; Sundaramoorthy R; Knebel A; Shaw GS; Walden H
    Nat Struct Mol Biol; 2017 May; 24(5):475-483. PubMed ID: 28414322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the human Parkin ligase domain in an autoinhibited state.
    Wauer T; Komander D
    EMBO J; 2013 Jul; 32(15):2099-112. PubMed ID: 23727886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation by PINK1 releases the UBL domain and initializes the conformational opening of the E3 ubiquitin ligase Parkin.
    Caulfield TR; Fiesel FC; Moussaud-Lamodière EL; Dourado DF; Flores SC; Springer W
    PLoS Comput Biol; 2014 Nov; 10(11):e1003935. PubMed ID: 25375667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoregulation of Parkin activity through its ubiquitin-like domain.
    Chaugule VK; Burchell L; Barber KR; Sidhu A; Leslie SJ; Shaw GS; Walden H
    EMBO J; 2011 Jun; 30(14):2853-67. PubMed ID: 21694720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring PARKIN RBR Ubiquitin Ligase Activation States with UbFluor.
    Foote PK; Statsyuk AV
    Curr Protoc Chem Biol; 2018 Sep; 10(3):e45. PubMed ID: 30063295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.